Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat in COPD
NCT00387088Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 31
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium with Placebo (2 arms). Primary endpoints: Change From Baseline in Trough Forced Expiratory Volume in 1 Second at Day 337 and Time to First Chronic Obstructive Pulmonary Disease (COPD) Exacerbation. Started Sep 2006; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00387088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387088.